MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga
MAIA Biotechnology, Inc. · PHARMACEUTICAL PREPARATIONS · Now $1.39
+13% in 7d after detection
Post-detection moves
1h
—
1d
+4.9%
3d
+4.1%
7d
+13%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS